Financials

News Ideas Technicals Forecast

MRNS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Marinus Pharmaceuticals, Inc.

Total assets of MRNS for Q1 24 is 137.35 M USD, 19.64% less than the previous Q4 23. And total liabilities decreased by 0.23% in Q1 24 to 153.78 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—